Weyand, C. M. & Goronzy, J. J. The immunology of rheumatoid arthritis. Nat. Immunol. 22, 10–18 (2021).

Article  CAS  PubMed  Google Scholar 

Felger, J. C. & Lotrich, F. E. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 246, 199–229 (2013).

Article  CAS  PubMed  Google Scholar 

Köhler, O. et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 71, 1381–1391 (2014).

Article  PubMed  Google Scholar 

Malhi, G. S. & Mann, J. J. Depression. Lancet 392, 2299–2312 (2018).

Article  PubMed  Google Scholar 

Otte, C. et al. Major depressive disorder. Nat. Rev. Dis. Prim. 2, 16065 (2016).

Article  PubMed  Google Scholar 

Schramm, E., Klein, D. N., Elsaesser, M., Furukawa, T. A. & Domschke, K. Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications. Lancet Psychiatry 7, 801–812 (2020).

Article  PubMed  Google Scholar 

Pezzato, S. et al. Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis. Adv. Rheumatol. 61, 57 (2021).

Article  PubMed  Google Scholar 

Rathbun, A. M., Reed, G. W. & Harrold, L. R. The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review. Rheumatology 52, 1785–1794 (2013).

Article  PubMed  Google Scholar 

Matcham, F., Rayner, L., Steer, S. & Hotopf, M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology 52, 2136–2148 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Sparks, J. A. et al. Depression and subsequent risk for incident rheumatoid arthritis among women. Arthritis Care Res. 73, 78–89 (2021).

Article  CAS  Google Scholar 

Drevets, W. C., Wittenberg, G. M., Bullmore, E. T. & Manji, H. K. Immune targets for therapeutic development in depression: towards precision medicine. Nat. Rev. Drug. Discov. 21, 224–244 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leighton, S. P. et al. Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis. Mol. Psychiatry 23, 48–58 (2018).

Article  CAS  PubMed  Google Scholar 

Matcham, F. et al. The relationship between depression and biologic treatment response in rheumatoid arthritis: an analysis of the British Society for Rheumatology Biologics Register. Rheumatology 57, 835–843 (2018).

Article  PubMed  Google Scholar 

Bullmore, E. The art of medicine: inflamed depression. Lancet 392, 1189–1190 (2018).

Article  PubMed  Google Scholar 

Beurel, E., Toups, M. & Nemeroff, C. B. The bidirectional relationship of depression and inflammation: double trouble. Neuron 107, 234–256 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nerurkar, L., Siebert, S., McInnes, I. B. & Cavanagh, J. Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiatry 6, 164–173 (2019).

Article  PubMed  Google Scholar 

McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205–2219 (2011).

Article  CAS  PubMed  Google Scholar 

Jaffe, D. H., Rive, B. & Denee, T. R. The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study. BMC Psychiatry 19, 247 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Chiu, W. C., Su, Y. P., Su, K. P. & Chen, P. C. Recurrence of depressive disorders after interferon-induced depression. Transl. Psychiatry 7, e1026 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Eyre, H. A. et al. A meta-analysis of chemokines in major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 68, 1–8 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chamberlain, S. R. et al. Treatment-resistant depression and peripheral C-reactive protein. Br. J. Psychiatry 214, 11–19 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Schett, G., McInnes, I. B. & Neurath, M. F. Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N. Engl. J. Med. 385, 628–639 (2021).

Article  CAS  PubMed  Google Scholar 

Wray, N. R. et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat. Genet. 50, 668–681 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levey, D. F. et al. Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions. Nat. Neurosci. 24, 954–963 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tylee, D. S. et al. Genetic correlations among psychiatric and immune-related phenotypes based on genome-wide association data. Am. J. Med. Genet. Part. B: Neuropsychiatr. Genet. 177, 641–657 (2018).

Article  Google Scholar 

Tartter, M., Hammen, C., Bower, J. E., Brennan, P. A. & Cole, S. Effects of chronic interpersonal stress exposure on depressive symptoms are moderated by genetic variation at IL6 and IL1β in youth. Brain Behav. Immun. 46, 104–111 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miller, A. H. & Raison, C. L. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 16, 22–34 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baumeister, D., Akhtar, R., Ciufolini, S., Pariante, C. M. & Mondelli, V. Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α. Mol. Psychiatry 21, 642–649 (2016).

Article  CAS  PubMed  Google Scholar 

Danese, A., Pariante, C. M., Caspi, A., Taylor, A. & Poulton, R. Childhood maltreatment predicts adult inflammation in a life-course study. Proc. Natl Acad. Sci. USA 104, 1319–1324 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khandaker, G. M., Pearson, R. M., Zammit, S., Lewis, G. & Jones, P. B. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 71, 1121–1128 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Kinne, R. W., Stuhlmüller, B. & Burmester, G. R. Cells of the synovium in rheumatoid arthritis. Macrophages. Arthritis Res. Ther. 9, 224 (2007).

Article  PubMed  PubMed Central  Google Scholar 

Gracie, J. A. et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J. Clin. Investig. 104, 1393–1401 (1999).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koo, J. W. & Duman, R. S. Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression. Curr. Opin. Investig. Drugs 10, 664 (2009).

CAS  PubMed  PubMed Central  Google Scholar 

Drago, A., Crisafulli, C., Calabrò, M. & Serretti, A. Enrichment pathway analysis. The inflammatory genetic background in bipolar disorder. J. Affect. Disord. 179, 88–94 (2015).

Article  PubMed  Google Scholar 

Alcocer-Gómez, E. et al. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav. Immun. 36, 111–117 (2014).

Article  PubMed  Google Scholar 

Maslanik, T. et al. Commensal bacteria and MAMPs are necessary for stress-induced increases in IL-1β and IL-18 but not IL-6, IL-10 or MCP-1. PLoS One 7, e50636 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Więdłocha, M. et al. Effect of antidepressant treatment on peripheral inflammation markers — a meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 80, 217–226 (2018).

Article  PubMed  Google Scholar 

Nakahara, H. et al. Anti-interleukin‐6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum. 48, 1521–1529 (2003).

Article  CAS